Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · IEX Real-Time Price · USD
0.634
-0.046 (-6.72%)
At close: Apr 24, 2024, 4:00 PM
0.635
+0.001 (0.08%)
After-hours: Apr 24, 2024, 7:58 PM EDT
Petros Pharmaceuticals Market Cap
Petros Pharmaceuticals has a market cap or net worth of $4.36 million as of April 24, 2024. Its market cap has decreased by -62.07% in one year.
Market Cap
4.36M
Enterprise Value
-961.05K
1-Year Change
-62.07%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since December 2, 2020, Petros Pharmaceuticals's market cap has decreased from $39.00M to $4.36M, a decrease of -88.82%. That is a compound annual growth rate of -47.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 4.40M | -6.38% |
Apr 23, 2024 | 4.70M | 4.44% |
Apr 22, 2024 | 4.50M | -2.17% |
Apr 19, 2024 | 4.60M | -4.17% |
Apr 18, 2024 | 4.80M | 2.13% |
Apr 17, 2024 | 4.70M | -2.08% |
Apr 16, 2024 | 4.80M | -11.11% |
Apr 15, 2024 | 5.40M | -5.26% |
Apr 12, 2024 | 5.70M | -9.52% |
Apr 11, 2024 | 6.30M | 3.28% |
Apr 10, 2024 | 6.10M | -3.17% |
Apr 9, 2024 | 6.30M | -1.56% |
Apr 8, 2024 | 6.40M | - |
Apr 5, 2024 | 6.40M | -3.03% |
Apr 4, 2024 | 6.60M | 3.13% |
Apr 3, 2024 | 6.40M | -13.51% |
Apr 2, 2024 | 7.40M | -22.92% |
Apr 1, 2024 | 9.60M | 190.91% |
Mar 28, 2024 | 3.30M | 3.13% |
Mar 27, 2024 | 3.20M | -5.88% |
Mar 26, 2024 | 3.40M | -2.86% |
Mar 25, 2024 | 3.50M | 6.06% |
Mar 22, 2024 | 3.30M | - |
Mar 21, 2024 | 3.30M | 6.45% |
Mar 20, 2024 | 3.10M | -3.13% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Exicure | 4.67M |
Sintx Technologies | 4.66M |
Sharps Technology | 4.56M |
Helius Medical Technologies | 4.50M |
Lipella Pharmaceuticals | 4.50M |
Seelos Therapeutics | 4.46M |
Processa Pharmaceuticals | 4.37M |
ZyVersa Therapeutics | 4.37M |